Role of pCO2 (AV gap) of Multi Organ Dysfunction Syndrome

dc.contributor.authorTarabrin, O.
dc.contributor.authorVasiliev, I.
dc.contributor.authorGroppa, S.
dc.contributor.authorGhicavii, V.
dc.contributor.authorD' Ambra, Mirta
dc.contributor.authorFriptu, V.
dc.contributor.authorGladun, S.
dc.contributor.authorDiug, V.
dc.contributor.authorSpinei, L.
dc.contributor.authorVartanov, V.
dc.contributor.authorStavrou, I.
dc.contributor.authorLitarczek, G.
dc.date.accessioned2023-04-25T11:56:36Z
dc.date.available2023-04-25T11:56:36Z
dc.date.issued2019
dc.descriptionVasiliev I. Role of pCO2 (AV gap) of Multi Organ Dysfunction Syndrome / I. Vasiliev, S. Groppa, V. Ghicavii, I. Stavrov, O. Tarabrin et al. // Journal of Biomedical and Pharmaceutical Sciences. - 2019. - Vol. 2, Issue 2. - P. 1–5.en_US
dc.description.abstractRecruitment of Microcirculatory-Mitochondrial (RMM) reduces Microcirculatory-Mitochondrial Distress Syndrome (MMDs), and Syndrome of Multi-Organ Dysfunction (MODs), by accelerated speed of delivery and return of blood flow which directly leads to a decrease in tissue hypoxia marker pCO2 (AV gap) and respectively with ↓ many other Endogenous Toxic Substances (ETS). In cases of pulmonary damage with ↑ pCO2 & ↓ Oxygenation Index PaO2 /FiO2 ↓ 300 the development of Acute Respiratory Distress Syndrome (ARDs), MMDs are also aggravated at ↑ with pCO2 AV gap. RMM also needs additional support of Multiple Organ Therapies-Multi-Organ Supportive Therapy (MOST), Alveolar Recruitment, Extracorporeal Life Support Organization (ELSO), Modeling of the Index of Extravascular Lung Fluid, EVLWI, Th4 - Th5 Thoracic Epidural Block, Active detoxification methods. The absence of decreasing of the pCO2 tissue hypoxia marker at the pCO2 AV gap ↓ 5.0 mmHg, after RMM proves the mitochondrial eu-energetic metabolic remodeling with the elimination of the hypo(an)ergic mitochondria performed by lysosomal clearance (mitophagy) makes the predominance eu-ergic mitochondria with the normalization of mitochondrial Ca++-uniporter-channel and mitochondrial permeability pore transition which productively inactivate the toxic forms of oxygen and nitrogen.en_US
dc.identifier.citationVasiliev I. Role of pCO2 (AV gap) of Multi Organ Dysfunction Syndrome / I. Vasiliev, S. Groppa, V. Ghicavii, I. Stavrov, O. Tarabrin et al. // Journal of Biomedical and Pharmaceutical Sciences. - 2019. - Vol. 2, Issue 2. - P. 1–5.en_US
dc.identifier.urihttps://hdl.handle.net/11300/24499
dc.language.isoenen_US
dc.subjectMicrocirculatory-Mitochondrial Distress Syndromeen_US
dc.subjectMicrocirculatory-Mitochondrial Recruitmenen_US
dc.subjectMultiple Organ Dysfunction Syndromeen_US
dc.subjectMarker of Tissue Hypoxia pCO2 (AV gap)en_US
dc.subjectAcute Respiratory Distress Syndromeen_US
dc.subjectMulti Organ Supportive Therapyen_US
dc.subjectMitochondral Remodelingen_US
dc.subjectMitochondrial Ca++ Uniporter Channelen_US
dc.subjectToxic forms of Oxygen and Nitrogenen_US
dc.subjectNascular Compliance ΔVPen_US
dc.titleRole of pCO2 (AV gap) of Multi Organ Dysfunction Syndromeen_US
dc.typeArticleen_US

Файли

Контейнер Original
Зараз відображається 1 - 1 з 1
Завантаження...
Ескіз
Name:
role-of-pco2-av-gap-of-multi-organ-dysfunction-syndrome (1).pdf
Size:
367.48 KB
Format:
Adobe Portable Document Format
Description:
Контейнер License
Зараз відображається 1 - 1 з 1
Без Ескізу
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: